Fig. 4From: Relationship between plasma circulating cell-free DNA concentration and treatment outcomes including prognosis in patients with advanced non-small cell lung cancerROC diagnostic efficacy of cfDNA (BT3, BT3-BT1) concentration to predict disease progressionBack to article page